This course has expired. View available courses.
Respirology
Respiratory Syncytial Virus (RSV) – Clinical Burden and Preventative Strategies
Clinicians play a key role in discussing the burden of respiratory syncytial virus (RSV) and initiating prophylaxis in eligible populations. The goal of this program is to raise awareness among healthcare practitioners (HCPs) of the clinical burden of RSV illness. The program will review which populations are at risk of RSV, the diagnosis of RSV, and preventative strategies.
DURATION
15 min
PROFESSION
Physician
# OF CREDITS
0.25
ACCREDITATION
Mainpro+
EXPIRY DATE
2024-01-17
Clinicians play a key role in discussing the burden of respiratory syncytial virus (RSV) and initiating prophylaxis in eligible populations.
The goal of this program is to raise awareness among healthcare practitioners (HCPs) of the clinical burden of RSV illness. The program will review which populations are at risk of RSV, the diagnosis of RSV, and preventative strategies.
This program has received financial support from Sanofi Pasteur in the form of an unrestricted educational grant.
Faculty
Taj Jadavji, MD, FRCPC, FAAP
Naomi Pliamm, MD, CCFP
Amudhinie Thanendran, MD, CCFP
Sofia Nastis, MD, CCFP
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- Discuss the clinical burden and presentation of RSV illness
- Describe how all healthy children are at risk for RSV illness
- Diagnose RSV illness in clinical practice
- Become aware of preventative strategies against RSV to inform parents of infants in the future